EUDA Health Holdings Limited
EUDANASDAQHealthcare● Active
$15.46
$-0.60(-3.74%)
Market Cap$28872199
P/E Ratio—
52W High$86
52W Low$5.26
EUDA Health Holdings Limited (EUDA) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
EUDA · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 28, 2026EPS Actual
$0.40
Est. $0.40 · +0.0%
Revenue
$0.01B
Est. $0.01B · -3.0%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 28, 2026
After Market Close
▼ Miss Revenue✓ 1-Quarter EPS Beat Streak
EUDA reports quarterly as a NASDAQ-listed Medical - Healthcare Information Services company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.21
Rev. $0.66B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.21
Rev. Est.$0.66B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 28, 2026 | $0.40 | — | — | — | $0.01B | — |
| ◌ Q2 FY2026 | May 5, 2026 | -$1.20 | — | — | — | $0.00B | — |
| — Q2 FY2026 | Apr 28, 2026 | $0.40 | $0.40 | +0.0% | $0.01B | $0.01B | -3.0% |
| ◌ Q4 FY2025 | Oct 1, 2025 | -$0.06 | — | — | $0.00B | $0.00B | -23.9% |
| — Q2 FY2025 | Jun 4, 2025 | — | -$0.32 | — | $0.00B | — | — |
| — Q4 FY2024 | Dec 31, 2024 | — | $0.40 | — | $0.00B | — | — |
| ▼ Q4 FY2024 | Nov 26, 2024 | -$0.02 | -$5.93 | -29557.0% | $0.00B | $0.00B | -28.8% |
| — Q3 FY2024 | Sep 26, 2024 | — | $0.40 | — | $0.00B | — | — |
Q3 FY2026
Jul 28, 2026
EPS Actual
—
EPS Est.
$0.40
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 5, 2026
EPS Actual
—
EPS Est.
-$1.20
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 28, 2026
EPS Actual
$0.40
EPS Est.
$0.40
EPS Surpr.
+0.0%
Revenue
$0.01B
Q4 FY2025
Oct 1, 2025
EPS Actual
—
EPS Est.
-$0.06
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2025
Jun 4, 2025
EPS Actual
-$0.32
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2024
Dec 31, 2024
EPS Actual
$0.40
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2024
Nov 26, 2024Miss
EPS Actual
-$5.93
EPS Est.
-$0.02
EPS Surpr.
-29557.0%
Revenue
$0.00B
Q3 FY2024
Sep 26, 2024
EPS Actual
$0.40
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $1.20 | $1.20 | $1.20 | 1 |
| Q3 FY2026 | $0.40 | $0.40 | $0.40 | 1 |
| Q2 FY2026 | $0.40 | $0.40 | $0.40 | 1 |
| Q1 FY2026 | $-1.20 | $-1.20 | $-1.20 | 1 |
| Q4 FY2025 | $-1.20 | $-1.20 | $-1.20 | 1 |
| Q3 FY2025 | $-0.06 | $-0.06 | $-0.06 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | Apr 28, 2026 | +0.0% | $12.86 | $12.00 | -6.69% |
| — Q2 FY2025 | Jun 4, 2025 | — | $66.40 | $63.60 | -4.22% |
| — Q4 FY2024 | Dec 31, 2024 | — | $88.80 | $89.40 | +0.68% |
| ▼ Q4 FY2024 | Nov 26, 2024 | -29557.0% | $86.40 | $87.80 | +1.62% |
| — Q3 FY2024 | Sep 26, 2024 | — | $76.80 | $81.20 | +5.73% |
| — Q1 FY2024 | Mar 31, 2024 | — | $36.00 | $36.60 | +1.67% |
| — Q4 FY2023 | Dec 31, 2023 | — | $28.60 | $30.40 | +6.29% |
| — Q3 FY2023 | Jul 31, 2023 | — | $11.20 | $11.20 | +0.00% |
Q2 FY2026-6.69%
Report Date
Apr 28, 2026
EPS Beat/Miss
+0.0%
Price Before
$12.86
Price After
$12.00
Q2 FY2025-4.22%
Report Date
Jun 4, 2025
EPS Beat/Miss
—
Price Before
$66.40
Price After
$63.60
Q4 FY2024+0.68%
Report Date
Dec 31, 2024
EPS Beat/Miss
—
Price Before
$88.80
Price After
$89.40
Q4 FY2024+1.62%
Report Date
Nov 26, 2024
EPS Beat/Miss
-29557.0%
Price Before
$86.40
Price After
$87.80
Q3 FY2024+5.73%
Report Date
Sep 26, 2024
EPS Beat/Miss
—
Price Before
$76.80
Price After
$81.20
Q1 FY2024+1.67%
Report Date
Mar 31, 2024
EPS Beat/Miss
—
Price Before
$36.00
Price After
$36.60
Q4 FY2023+6.29%
Report Date
Dec 31, 2023
EPS Beat/Miss
—
Price Before
$28.60
Price After
$30.40
Q3 FY2023+0.00%
Report Date
Jul 31, 2023
EPS Beat/Miss
—
Price Before
$11.20
Price After
$11.20
Avg Beat Reaction-6.69%
Avg Miss Reaction+1.62%
Beat Rate1 / 8 quarters
Largest Move-6.69% (Q2 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: EUDA ends December
EUDA Health Holdings Limited (EUDA) most recently reported earnings on April 28, 2026 for Q2 FY2026, posting EPS of $0.40 (in line with the analyst consensus of $0.40). The next EUDA earnings date is expected around September 1, 2026.
Each quarter, investors track EUDA earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. EUDA revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
EUDA's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
EUDA earnings · 4 questionsEUDA Health Holdings Limited's next earnings report is expected around September 1, 2026. EUDA typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; EUDA historically reports after market close (AMC).
EUDA earnings datewhen is EUDA earningsEUDA next earnings datewhen does EUDA report earningsEUDA earnings calendar
▸ Source: FMP · EUDA Health Holdings Limited SEC filings · US GAAP · EUDA Health Holdings Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026